Dr. Charles Pewitt, DO

NPI: 1740389980
Total Payments
$25,061
2024 Payments
$2,432
Companies
63
Transactions
1,597
Medicare Patients
20,840
Medicare Billing
$2.1M

Payment Breakdown by Category

Food & Beverage$24,728 (98.7%)
Education$333.11 (1.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $24,728 1,583 98.7%
Education $333.11 14 1.3%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $3,969 236 $0 (2024)
AstraZeneca Pharmaceuticals LP $2,644 115 $0 (2024)
Novo Nordisk Inc $1,739 131 $0 (2024)
Janssen Pharmaceuticals, Inc $1,585 106 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,557 76 $0 (2024)
GlaxoSmithKline, LLC. $1,432 95 $0 (2024)
Lilly USA, LLC $1,124 77 $0 (2024)
Amgen Inc. $978.90 52 $0 (2024)
Novartis Pharmaceuticals Corporation $936.41 65 $0 (2024)
PFIZER INC. $873.86 86 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,432 140 ABBVIE INC. ($743.73)
2023 $3,312 200 ABBVIE INC. ($1,122)
2022 $3,883 232 ABBVIE INC. ($1,262)
2021 $3,964 263 AbbVie Inc. ($830.06)
2020 $3,060 226 AstraZeneca Pharmaceuticals LP ($530.43)
2019 $3,182 205 Janssen Pharmaceuticals, Inc ($512.15)
2018 $2,994 192 Boehringer Ingelheim Pharmaceuticals, Inc. ($402.74)
2017 $2,234 139 AstraZeneca Pharmaceuticals LP ($269.14)

All Payment Transactions

1,597 individual payment records from CMS Open Payments — Page 1 of 64

Date Company Product Nature Form Amount Type
12/30/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $10.32 General
Category: NEUROSCIENCE
12/19/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $24.26 General
Category: GASTROENTEROLOGY
12/17/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $8.34 General
Category: Diabetes
12/06/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $20.15 General
Category: PSYCHIATRY
12/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $22.74 General
Category: PSYCHIATRY
12/03/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $15.41 General
Category: Cardiology/Vascular Diseases
11/27/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.04 General
Category: Gastroenterology
11/23/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $10.33 General
Category: NEUROSCIENCE
11/20/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $14.85 General
Category: Anticholinergics, Inhaled
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.36 General
Category: NEUROSCIENCE
11/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $17.25 General
Category: Diabetes
11/12/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $11.18 General
Category: RESPIRATORY
11/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.87 General
Category: NEUROSCIENCE
11/11/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $11.21 General
Category: NEUROSCIENCE
11/07/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $34.07 General
Category: NEUROSCIENCE
11/04/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.60 General
Category: Cardiovascular and Metabolism
11/01/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $27.04 General
10/24/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $6.50 General
Category: NEUROSCIENCE
10/21/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.12 General
Category: NEUROSCIENCE
10/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $33.76 General
Category: NEUROSCIENCE
10/14/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $15.35 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/11/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.57 General
Category: NEUROSCIENCE
10/04/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $24.75 General
Category: PSYCHIATRY
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $14.54 General
Category: Gastroenterology
09/30/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $15.97 General
Category: ANTILIPEMIC AGENTS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 33 4,372 13,146 $1.1M $554,334
2022 37 5,153 13,941 $1.1M $573,724
2021 34 5,595 13,795 $913,736 $519,939
2020 47 5,720 14,205 $931,163 $487,881
Total Patients
20,840
Total Services
55,087
Medicare Billing
$2.1M
Procedure Codes
151

All Medicare Procedures & Services

151 procedure records from CMS Medicare Utilization — Page 1 of 7

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 414 2,081 $291,340 $177,119 60.8%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 269 2,112 $211,200 $93,689 44.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 283 768 $69,120 $48,471 70.1%
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes Office 2023 85 1,343 $102,068 $37,740 37.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 262 262 $41,920 $31,574 75.3%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 94 960 $91,200 $30,624 33.6%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 93 900 $82,800 $30,376 36.7%
76775 Limited ultrasound scan behind abdominal cavity Office 2023 327 337 $53,920 $13,129 24.3%
99484 Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional Office 2023 79 410 $22,550 $12,862 57.0%
90756 Influenza vaccine, quadrivalent derived from cell cultures Office 2023 233 234 $9,345 $7,290 78.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 234 703 $18,981 $6,420 33.8%
G0008 Administration of influenza virus vaccine Office 2023 226 227 $6,810 $6,414 94.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 36 43 $8,600 $5,757 66.9%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 62 163 $12,225 $5,658 46.3%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 332 332 $24,900 $5,423 21.8%
90670 Pneumococcal vaccine, 13-valent Office 2023 23 23 $6,900 $5,309 76.9%
36415 Insertion of needle into vein for collection of blood sample Office 2023 349 600 $9,000 $5,040 56.0%
99487 Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 32 49 $7,350 $4,738 64.5%
90732 Pneumococcal vaccine, 23-valent Office 2023 34 34 $5,950 $4,316 72.5%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2023 26 26 $5,200 $4,026 77.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 336 370 $24,050 $3,468 14.4%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 223 419 $12,570 $3,417 27.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 16 16 $2,560 $1,899 74.2%
99495 Transitional care management services for problem of at least moderate complexity Office 2023 12 12 $3,000 $1,814 60.5%
17000 Destruction of precancer skin growth, 1 growth Office 2023 22 30 $4,500 $1,294 28.8%

About Dr. Charles Pewitt, DO

Dr. Charles Pewitt, DO is a Family Medicine healthcare provider based in Jackson, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740389980.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Pewitt, DO has received a total of $25,061 in payments from pharmaceutical and medical device companies, with $2,432 received in 2024. These payments were reported across 1,597 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($24,728).

As a Medicare-enrolled provider, Pewitt has provided services to 20,840 Medicare beneficiaries, totaling 55,087 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Jackson, MO
  • Active Since 09/22/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1740389980

Products in Payments

  • UBRELVY (Drug) $2,764
  • XARELTO (Drug) $1,157
  • FARXIGA (Drug) $1,076
  • Ozempic (Drug) $1,019
  • VRAYLAR (Drug) $936.44
  • TRELEGY ELLIPTA (Drug) $935.77
  • ENTRESTO (Drug) $850.46
  • BREZTRI (Drug) $809.12
  • QULIPTA (Drug) $800.94
  • XIFAXAN (Drug) $538.72
  • Vascepa (Drug) $519.66
  • JARDIANCE (Drug) $488.28
  • TRADJENTA (Drug) $471.15
  • REXULTI (Drug) $414.17
  • Livalo (Drug) $411.03
  • SYMBICORT (Drug) $404.14
  • Kerendia (Drug) $392.57
  • NEXLETOL (Drug) $367.64
  • SPIRIVA RESPIMAT (Drug) $356.53
  • EMGALITY (Drug) $346.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Jackson